The Human Digestive Tract Is Capable of Degrading Gluten from Birth
Open Access
- 17 October 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20), 7696
- https://doi.org/10.3390/ijms21207696
Abstract
The human gastrointestinal system has the capacity to metabolize dietary gluten. The capacity to degrade gliadin-derived peptide is present in humans from birth and increases during the first stages of life (up to 6–12 months of age). Fecal samples from 151 new-born and adult non-celiac disease (NCD) volunteers were collected, and glutenase and glianidase activities were evaluated. The capacity of total fecal proteins to metabolize 33-mer, 19-mer, and 13-mer gliadin peptides was also evaluated by high-performance liquid chromatography (HPLC). Feces from new-borns (meconium) showed glutenase and gliadinase activities, and peptidase activity against all three gliadin peptides. Maximal gluten degradative activity was observed in fecal samples from the youngest volunteers (0–12 months old). After the age of nine months, the gluten digestive capacity of gastrointestinal tract decreases and, from ±8 years old, individuals lose the ability to completely degrade toxic peptides. The gastrointestinal proteases involved in gluten digestion: elastase 2A, elastase 3B, and carboxipeptidase A1 are present from earlier stages of life. The human digestive tract contains the proteins capable of metabolizing gluten from birth, even before starting gluten intake. Humans are born with the ability to digest gluten and to completely degrade the potentially toxic gliadin-derived peptides (33-, 19-, and 13-mer).Keywords
This publication has 25 references indexed in Scilit:
- Protease inhibition as new therapeutic strategy for GI diseasesGut, 2016
- Coeliac disease and gluten-related disorders in childhoodNature Reviews Gastroenterology & Hepatology, 2015
- Age-related differences in celiac disease: Specific characteristics of adult presentationWorld Journal of Gastrointestinal Pharmacology and Therapeutics, 2015
- Risk of Pediatric Celiac Disease According to HLA Haplotype and CountryNew England Journal of Medicine, 2014
- Celiac DiseaseJAMA Pediatrics, 2014
- A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activityEuropean Journal of Nutrition, 2011
- Celiac Disease: From Pathogenesis to Novel TherapiesGastroenterology, 2009
- Age-Related Clinical, Serological, and Histopathological Features of Celiac DiseaseThe American Journal of Gastroenterology, 2008
- Chemistry of gluten proteinsFood Microbiology, 2007
- Molecular Basis of Celiac DiseaseAnnual Review of Immunology, 2000